Literature DB >> 9137973

Experimental plasmacytomagenesis in mice.

M Potter1.   

Abstract

This article discusses some of the mechanistic aspects of plasma cell tumor development. Plasmacytomagenesis, much like other forms of neoplastic development, is a highly complex process that develops in the B cell differentiation lineage. As more is learned about the molecular genetics of multiple myeloma and PCTs in mice, a unifying concept will emerge that possibly can explain the phenotypic differences in the two neoplastic cell processes as variants of a common process.

Entities:  

Mesh:

Year:  1997        PMID: 9137973     DOI: 10.1016/s0889-8588(05)70434-2

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

1.  Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP.

Authors:  A L Kung; V I Rebel; R T Bronson; L E Ch'ng; C A Sieff; D M Livingston; T P Yao
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

2.  Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.

Authors:  Wan Cheung Cheung; Joong Su Kim; Michael Linden; Liangping Peng; Brian Van Ness; Roberto D Polakiewicz; Siegfried Janz
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

3.  The impact of p53 loss on murine plasmacytoma development.

Authors:  Sabine Mai; Francis Wiener
Journal:  Chromosome Res       Date:  2002       Impact factor: 5.239

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.